Data updated: Mar 10, 2026
MEPROBAMATE
MEPROBAMATE
Approved 1963-07-26
24
Indications
--
Phase 3 Trials
62
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1963-07-26
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
WHITEWORTH TOWN PLSN PUREPAC PHARM LEDERLE RISING SCHERER LABS WATSON LABS USL PHARMA ALEMBIC PHARMS LTD TABLICAPS PHARMAVITE TARO HEATHER ROXANE PVT FORM ACELLA SOLVAY PERRIGO Novartis IVAX SUB TEVA PHARMS VANGARD LEE KM IMPAX LABS MALLARD Sun Pharma Viatris NEXGEN PHARMA INC VALEANT PHARM INTL INVAGEN PHARMS ELKINS SINN Teva PARKE DAVIS MK LABS STANLABS PHARM CHARTWELL MOLECULAR Hikma
Active Ingredient: MEPROBAMATE
Website: ↗
MEPROBAMATE Approval History
Loading approval history...
What MEPROBAMATE Treats
24 FDA approvalsOriginally approved for its first indication in 1963 . Covers 24 distinct patient populations.
- Other (24)
Other
(24 approvals)- • Approved indication (Jul 1963)
- • Approved indication (Aug 1963)
- • Approved indication (Apr 1964)
- • Approved indication (Dec 1964)
- • Approved indication (Jul 1972)
- • Approved indication (Oct 1972)
- • Approved indication (Apr 1973)
- • Approved indication (May 1973)
- • Approved indication (Dec 1973)
- • Approved indication (Feb 1974)
- • Approved indication (Apr 1974)
- • Approved indication (Jul 1974)
- • Approved indication (Jul 1974)
- • Approved indication (Sep 1974)
- • Approved indication (Apr 1975)
- • Approved indication (Dec 1975)
- • Approved indication (Nov 1976)
- • Approved indication (Jul 1977)
- • Approved indication (Mar 1982)
- • Approved indication (Jul 1982)
- • Approved indication (Nov 1987)
- • Approved indication (Feb 2008)
- • Approved indication (Feb 2009)
- • Approved indication (May 2011)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MEPROBAMATE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.